EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The 8th International RASopathies Symposium : Expanding research and care practice through global collaboration and advocacy

Elizabeth I Pierpont iD, Anton M Bennett, Lisa Schoyer iD, Beth Stronach, April Anschutz, Sarah C Borrie, Benjamin Briggs, Emma Burkitt-Wright, Pau Castel, Ion C Cirstea, Fieke Draaisma, Michelle Ellis und 32 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Elizabeth I Pierpont und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Costello Syndrome, Neoplasms, Ectodermal Dysplasia, Noonan Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Doris Duke Charitable Foundation, NHLBI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline pathogenic variants in the RAS/mitogen‐activated protein kinase (MAPK) signaling pathway are the molecular cause of RASopathies, a group of clinically overlapping genetic syndromes. RASopathies constitute a wide clinical spectrum characterized by distinct facial features, short stature, predisposition to cancer, and variable anomalies in nearly all the major body systems. With increasing global recognition of these conditions, the 8th International RASopathies Symposium spotlighted global perspectives on clinical care and research, including strategies for building international collaborations and developing diverse patient cohorts in anticipation of interventional trials. This biannual meeting, organized by RASopathies Network, was held in a hybrid virtual/in‐person format. The agenda featured emerging discoveries and case findings as well as progress in preclinical and therapeutic pipelines. Stakeholders including basic scientists, clinician‐scientists, practitioners, industry representatives, patients, and family advocates gathered to discuss cutting edge science, recognize current gaps in knowledge, and hear from people with RASopathies about the experience of daily living. Presentations by RASopathy self‐advocates and early‐stage investigators were featured throughout the program to encourage a sustainable, diverse, long‐term research and advocacy partnership focused on improving health and bringing treatments to people with RASopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Costello SyndromeNeoplasmsEctodermal DysplasiaNoonan SyndromeHeart Defects, CongenitalHumansras ProteinsMAP Kinase Signaling System

Stichwörter der Autor:innen

Costello syndromeNoonan syndromecardio-facio-cutaneus syndromeneurofibromatosissignalingtherapeutics

Substanzen

ras Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA.
  • RASopathies Network, Los Angeles, California, USA.
  • KU Leuven, Laboratory for the Research of Neurodegenerative Diseases, Leuven, Belgium.
  • School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust and University of Manchester, Manchester, UK.

ORCID-Profile: Elizabeth I Pierpont, Lisa Schoyer, Bruce D Gelb, Sattar Khoshkhoo, Bonita P Klein-Tasman, Maria I Kontaridis, Paul Kruszka, Chiara Leoni, Katherine A Rauen, Martin Zenker

Förderung

  • Doris Duke Charitable Foundation
  • NHLBI NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • BioMarin Pharmaceutical
  • Boehringer Ingelheim

Zitieren

APA

Pierpont, E. I., Bennett, A. M., Schoyer, L., Stronach, B., Anschutz, A., Borrie, S. C., Briggs, B., Burkitt-Wright, E., Castel, P., Cirstea, I. C., Draaisma, F., Ellis, M., Fear, V. S., Frone, M. N., Flex, E., Gelb, B. D., Green, T., Gripp, K. W., Khoshkhoo, S., …, & Andelfinger, G. (2024). The 8th International RASopathies Symposium : Expanding research and care practice through global collaboration and advocacy. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63477

Vancouver

Pierpont EI, Bennett AM, Schoyer L, Stronach B, Anschutz A, Borrie SC, et al. The 8th International RASopathies Symposium : Expanding research and care practice through global collaboration and advocacy. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63477

BibTeX
@article{Pierpont2024,
  author = {Pierpont, Elizabeth I and Bennett, Anton M and Schoyer, Lisa and Stronach, Beth and Anschutz, April and Borrie, Sarah C and Briggs, Benjamin and Burkitt-Wright, Emma and Castel, Pau and Cirstea, Ion C and Draaisma, Fieke and Ellis, Michelle and Fear, Vanessa S and Frone, Megan N and Flex, Elisabetta and Gelb, Bruce D and Green, Tamar and Gripp, Karen W and Khoshkhoo, Sattar and Kieran, Mark W and Kleemann, Karolin and Klein-Tasman, Bonita P and Kontaridis, Maria I and Kruszka, Paul and Leoni, Chiara and Liu, Clifford Z and Merchant, Nadia and Magoulas, Pilar L and Moertel, Christopher and Prada, Carlos E and Rauen, Katherine A and Roelofs, Renée and Rossignol, Rodrigue and Sevilla, Christine and Sevilla, Gigi and Sheedy, Ryan and Stieglitz, Elliot and Sun, Daochun and Tiemens, Dagmar and White, Forest and Wingbermühle, Ellen and Wolf, Cordula and Zenker, Martin and Andelfinger, Gregor},
  title = {The 8th International RASopathies Symposium : Expanding research and care practice through global collaboration and advocacy},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63477}
}
Kostenlos starten →